Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0251 | 0.0609 | 1 |
Schistosoma mansoni | 3-dehydroquinate synthase | 0.0128 | 0.0245 | 0.4021 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.055 | 0.1491 | 0.2699 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0591 | 0.1614 | 0.1404 |
Wolbachia endosymbiont of Brugia malayi | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 0.0201 | 0.0461 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0062 | 0.103 |
Mycobacterium ulcerans | chorismate synthase | 0.3426 | 1 | 1 |
Toxoplasma gondii | chorismate synthase, putative | 0.3426 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0169 | 0.0365 | 0.6439 |
Plasmodium vivax | chorismate synthase | 0.3426 | 1 | 0.5 |
Chlamydia trachomatis | phosphoshikimate 1-carboxyl vinyltransferase | 0.033 | 0.0841 | 0.0611 |
Mycobacterium ulcerans | 3-phosphoshikimate 1-carboxyvinyltransferase | 0.033 | 0.0841 | 0.0611 |
Schistosoma mansoni | hypothetical protein | 0.0169 | 0.0365 | 0.5992 |
Echinococcus granulosus | geminin | 0.0169 | 0.0365 | 0.6439 |
Echinococcus granulosus | cdgsh iron sulfur domain containing protein | 0.0237 | 0.0567 | 1 |
Brugia malayi | Uncharacterized hematopoietic stem/progenitor cells protein MDS029 | 0.0101 | 0.0163 | 0.2056 |
Mycobacterium leprae | Chorismate synthase AroF (5-enolpyruvylshikimate-3-phosphate phospholyase). | 0.1689 | 0.4863 | 1 |
Schistosoma mansoni | CDGSH-type Zn finger-containing protein-like protein | 0.0251 | 0.0609 | 1 |
Mycobacterium tuberculosis | Probable chorismate synthase AroF (5-enolpyruvylshikimate-3-phosphate phospholyase) | 0.1689 | 0.4863 | 1 |
Onchocerca volvulus | 0.0101 | 0.0163 | 0.5 | |
Echinococcus multilocularis | cdgsh iron sulfur domain containing protein | 0.0237 | 0.0567 | 1 |
Schistosoma mansoni | alzheimer's disease beta-amyloid related | 0.0115 | 0.0204 | 0.3351 |
Mycobacterium leprae | probable 3-phosphoshikimate 1-carboxyvinyl transferase AroA (5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE) (EPSP SYNTHASE) (EPSPS | 0.033 | 0.0841 | 0.1291 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0259 | 0.4328 |
Treponema pallidum | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 0.0201 | 0.0461 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.0163 | 0.2734 |
Brugia malayi | Amyloid A4 extracellular domain containing protein | 0.0314 | 0.0795 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0169 | 0.0365 | 0.5992 |
Chlamydia trachomatis | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 0.0201 | 0.0461 | 0.0222 |
Plasmodium falciparum | chorismate synthase | 0.3426 | 1 | 0.5 |
Mycobacterium ulcerans | UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 0.0201 | 0.0461 | 0.0222 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0591 | 0.1614 | 0.1404 |
Loa Loa (eye worm) | hypothetical protein | 0.0248 | 0.0598 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 9 % | Inhibition of CXCL8-induced chemotaxis of human polymorphonuclear cells at 10e-8 M | ChEMBL. | 15974585 |
Inhibition (functional) | = 9 % | Inhibition of CXCL8-induced chemotaxis of human polymorphonuclear cells at 10e-8 M | ChEMBL. | 15974585 |
Inhibition (functional) | = 30 % | Inhibition of interleukin-8 induced chemotaxis of human polymorphonuclear cells at 100 nM | ChEMBL. | 15974585 |
Inhibition (functional) | = 30 % | Inhibition of interleukin-8 induced chemotaxis of human polymorphonuclear cells at 100 nM | ChEMBL. | 15974585 |
Inhibition (functional) | = 63 % | Inhibition of lipopolysaccharide-induced PGE-2 production at 10e-5 M | ChEMBL. | 15974585 |
Inhibition (functional) | = 63 % | Inhibition of lipopolysaccharide-induced PGE-2 production at 10e-5 M | ChEMBL. | 15974585 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.